收藏切换
Advances in the B cell lymphoma-2 inhibitors
收藏切换
Ruling ZHENG, Jianzhong SHENTU*
World Clinical Drug | 2023, 44(11) : 1226 - 1231
Less
收藏切换
World Clinical Drug | 2023, 44(11): 1226-1231
• Review •
Advances in the B cell lymphoma-2 inhibitors
Full
Ruling ZHENG, Jianzhong SHENTU*
Affiliations
  • Innovation Centre for Advanced Interdisciplinary Medicine, the Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, Guangdong Province, China
Published: 2023-11-10 doi: 10.13683/j.wph.2023.11.017
Outline
收藏切换

B cell lymphoma (Bcl)-2 gene is mainly expressed in the outer mitochondrial membrane. It is the major regulator in the apoptotic signaling pathway, and its aberrant expression is closely related to tumor development. Bcl-2 protein, encoded by Bcl-2 gene, regulates apoptosis through protein-protein interactions and has become an important target for the treatment of chronic lymphocytic leukemia (CLL). Most of the Bcl-2 inhibitors are small molecule compounds. Fragment-based drug design approaches that mimic the BH3 structural domain of the Bcl-2 protein have driven the development of Bcl-2 inhibitors. The currently marketed Bcl-2-targeted inhibitor drug venetoclax can effectively treat CLL and small lymphocytic leukemia, and shows better clinical efficacy in B-lymphocyte malignancies, and other Bcl-2 inhibitor drugs that have entered clinical studies also show better development prospects. This article reviewed the mechanism of Bcl-2, and summarized the research progress of Bcl-2 inhibitors in recent years, to provide insights for the further development of Bcl-2 inhibitors.

B cell lymphoma-2  /  inhibitor  /  apoptosis  /  venetoclax
郑如玲, 申屠建中. B淋巴细胞瘤-2抑制剂的研究进展. 世界临床药物, 2023 , 44 (11) : 1226 -1231 . DOI: 10.13683/j.wph.2023.11.017
Ruling ZHENG, Jianzhong SHENTU. Advances in the B cell lymphoma-2 inhibitors[J]. World Clinical Drug, 2023 , 44 (11) : 1226 -1231 . DOI: 10.13683/j.wph.2023.11.017
Year 2023 volume 44 Issue 11
11
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.11.017
  • Receive Date:2022-06-13
  • Online Date:2026-11-18
  • Published:2023-11-10
Article Data
Affiliations
History
  • Received:2022-06-13
Affiliations
    Innovation Centre for Advanced Interdisciplinary Medicine, the Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, Guangdong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.11.017
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT